This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Revivicor, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Carol Phelps: Innovator in Medical Immunology
Introduction: Carol Phelps is a notable inventor in the field of medical immunology. She has made significant contributions to the development of vaccines, particularly against Clostridium difficile. Her work focuses on creating effective pharmaceutical compositions that can enhance public health.
Latest Patents: Carol Phelps is credited with the invention of the Recombinant Toxin A/Toxin B Vaccine Against Clostridium Difficile. This invention relates to recombinant proteins derived from the genes encoding Clostridium difficile toxin A and toxin B. The vaccine aims to provide an active immunization strategy against C. difficile infections.
Career Highlights: Carol Phelps has been associated with Intercell USA, Inc., where she has contributed her expertise in vaccine development. Her innovative approach to immunology has positioned her as a key figure in the fight against infectious diseases.
Collaborations: Carol has worked alongside notable colleagues such as Tracy D. Wilkins and David Maxwell Lyerly. Their collaborative efforts have further advanced the research and development of effective vaccines.
Conclusion: Carol Phelps is a pioneering inventor whose work in medical immunology has the potential to significantly impact public health through innovative vaccine development. Her contributions are vital in the ongoing battle against infectious diseases.